SCHEMBL7744087

SCHEMBL7744087

O=C(Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccc(C(F)(F)F)cc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.46
FLT1 P17948 1/20 0.46
FLT4 P35916 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
ADCY1 Q08828 1/20 0.45
ALDH1A1 P00352 1/20 0.43
TP53 P04637 2/20 0.43
P2RX1 P51575 2/20 0.42
HDAC2 Q92769 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
NTRK1 P04629 1/20 0.40
THRB P10828 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
KCNK3 O14649 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746601 0.92 KDR (0.53) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7746620 0.89 KDR (0.57) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7985540 0.88 KDR (0.47) KDRFLT1FLT4MEN1LMNA
SCHEMBL7744086 0.85 KDR (0.51) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7744061 0.84 KDR (0.50) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7746631 0.84 KDR (0.42) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7744781 0.83 ADCY1 (0.47) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7744170 0.83 F2 (0.45) KDRFLT1FLT4NPC1RAB9A
SCHEMBL7746655 0.83 KDR (0.43) KDRFLT1FLT4NPC1MAPT
SCHEMBL7739071 0.83 KDR (0.43) KDRFLT1FLT4NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed